Interaction of vesicular stomatitis virus-G pseudotyped retrovirus with CD34+ and CD34+CD38- hematopoietic progenitor cells

Gene Therapy

Volumn 4, Issue 9, 1997, Pages 918-927

  Sinclair, A M ^a   Agrawal, Y P ^b   Elbar, E ^c   Agrawal, R ^d   Ho, A D ^c   Levine, F ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d AIV Institute   (Finland)

Author keywords

CD34+; CD34+CD38 ; Gene therapy; Hematopoietic stem cell; Retrovirus; VSV G pseudotype

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; RHODAMINE; VIRUS PROTEIN; VIRUS RECEPTOR;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION; TEMPERATURE; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION;

EID: 0030847416     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300479     Document Type: Article

References (51)

1. Kohn DB. The current status of gene therapy using hematopoietic stem cells. Curr Opin Pediatr 1995, 7: 56-63.
2. +/38lo human marrow cells after in vitro cytokine exposure. Blood 1995; 85: 1480-1487.
3. - cells. Exp Hematol 1996; 24: 738-747.
4. Berardi AC et al. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267: 104-108.
5. Kohn DB et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1995; 1: 1017-1023.
6. Brenner MK et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients Lancet 1993; 342: 1134-1137.
7. Dunbar CE et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048-3057
8. Richardson C, Ward M, Podda S, Bank A. Mouse fetal liver cells lack functional amphotropic retroviral receptors. Blood 1994; 84: 433-439
9. Crooks GM, Kohn DB Growth factors increase amphotropic retrovirus binding to human CD34+ bone marrow progenitor cells. Blood 1993; 82: 3290-3297.
10. Orlic D et al. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci USA 1996; 93: 11097-11102.
11. Spector DH et al. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol 1990; 64: 2298-2308.
12. Miller AD et al. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 1991; 65: 2220-2224.
13. Love DN, Weiss RA. Pseudotypes of vesicular stomatitis virus determined by exogenous and endogenous avian RNA tumor viruses. Virology 1974; 57: 217-278.
14. Livingstone DM, Howard T, Spence C. Identification of infectious virions which are vesicular stomatitis virus pseudotypes of murine type C virus. Virology 1976; 70: 432-439.
15. Weiss RA, Boetigger D, Murphy HM. Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus. Virology 1977; 76: 808-825.
16. Witte ON, Baltimore D. Mechanisms of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus. Cell 1977; 11: 505-511.
17. Weiss RA. Human receptors for retroviruses. In: Wimmer E (ed). Cellular Receptors For Animal Viruses. Monograph 28. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1994, pp 15-31.
18. Von Kalle C et al. Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood 1994; 84: 2890-2897.
19. Kavanaugh MP et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are sodium- dependent phosphate symporters. Proc Natl Acad Sci USA 1994; 91: 7071-7075.
20. Burns J et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titers and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033-8037.
21. Yee JK et al. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 1994; 91: 9564-9568.
22. Schlegel R, Tralka TS, Willingham MC, Pastan I. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 1983; 32: 639-646.
23. Conti C, Mastromarino P, Orsi N. Role of membrane phospholipids and glycolipids in cell-to-cell fusion by VSV. Comp Immun Microbiol Infect Dis 1991; 14: 303-313.
24. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol 1992; 66: 4893-4900.
25. Schloemer RH, Wagner RR. Mosquito cells infected with vesicular stomatitis virus yield unsialylated virions of low infectivity. J Virol 1975; 15: 1029-1032.
26. Levinson W, Oppermann H, Rubenstein P, Jackson J. Host range restriction of vesicular stomatitis virus on duck embryo cells. Virology 1978; 85: 612-616.
27. Lefrancois L, Lyles DS. The interactions of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and crossreactive epitopes of Indiana and New Jersey serotypes. Virology 1982; 121: 414-426.
28. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Meth 1995; 184: 39-51.
29. Koopman G et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-1420.
30. Siningil F, Loyter A, Volsky DJ. Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching. FEBS Lett 1988; 239: 88-92.
31. Puri A, Krumbiegel M, Dimitrov D, Blumenthal R. A new approach to measure fusion activity of cloned viral envelope proteins: fluorescence dequenching of octadecylrhodamine-labeled plasma membrane vesicles fusing with cells expressing vesicular stomatitis virus glycoprotein Virology 1993; 195: 855-858.
32. Arbuzova A, Korte T, Müller P, Herrmann A. On the validity of lipid dequenching assays for estimating virus fusion kinetics. Biochim Biophys Acta 1994; 1190: 360-366.
33. Ohashi M, Murata M, Ohnishi S. A novel fluorescence method to monitor the lysosomal disintegration of low density lipoprotein. Eur J Cell Biol 1992; 59: 116-126.
34. - progenitor cells. Blood 1991; 77: 1218-1227.
35. + bone marrow cells. Blood 1994; 84: 1473-1481.
36. Yu H, Soong N, Anderson WF. Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J Virol 1995; 69: 6557-6562.
37. Seigneuret M, Devaux PF. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci USA 1984; 81: 3751-3755.
38. Zachowski A, Herrmann A, Paraf A, Devaux PF. Phospholipid outside-inside translocation in lymphocyte plasma membranes is a protein-mediated phenomenon. Biochim Biophys Acta 1987; 897: 197-200.
39. Martin OC, Pagano RE. Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanolamine at the plasma membrane of cultured cells. Evidence for a protein-mediated and ATP-dependent process(es). J Biol Chem 1987; 262: 5890-5898.
40. Bogdanov A, Verhoven B, Schlegel RA, Williamson P. Asymmetry in transbilayer lateral pressure may drive expansion of the secretion fusion pore. Biochem Soc Trans 1993; 21: 271-275.
41. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182: 1597-1601.
42. Mantel C, Luo Z, Hendrie P, Broxmeyer HE. Steel factor and granulocyte-macrophage colony-stimulating factor act together to enhance choline-lipid turnover during synergistically stimulated proliferation of the human factor-dependent cell line M07e. Biochem Biophys Res Commun 1993; 197: 978-984.
43. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retrovirus-mediated transduction of primitive human hematopoietic cells. Blood 1995; 86: 101-110.
44. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
45. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis envelope glycoprotein G. J Virol 1996; 70: 2581-2585.
46. Poeschla E, Corbeau P, Wong-Staal F. Development of HIV vectors for anti-HIV gene therapy. Proc Natl Acad Sci USA 1996; 93: 11395-11399.
47. Naldini L et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93: 11382-11388.
48. Zack JA, Haislip AM, Krogstad P, Chen ISY. Incompletely reverse-transcribed human immunodeficiency virus type genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 1992; 66: 1717-1725.
49. Cohen A, Barankiewicz J, Lederman HM, Gelfand EW. Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem 1983; 258: 12334-12340.
50. McCormick PJ, Danhauser LL, Rustum YM, Bertram JS. Changes in ribo- and deoxyribonucleoside triphosphate pools within the cell cycle of a synchronized mouse fibroblast cell line. Biochim Biophys Acta 1983; 756: 36-40.
51. Lane TA et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GMCSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.